UNICARB 150MG INJECTION 15ML
About UNICARB 150MG INJECTION 15ML
UNICARB 150MG INJECTION 15ML belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
UNICARB 150MG INJECTION 15ML contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.
UNICARB 150MG INJECTION 15ML is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of UNICARB 150MG INJECTION 15ML do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
To treat your condition effectually, continue taking UNICARB 150MG INJECTION 15ML for as long as your doctor has prescribed. Do not stop the UNICARB 150MG INJECTION 15ML midway. Talk to your doctor before taking UNICARB 150MG INJECTION 15ML if you have severe allergic reactions to UNICARB 150MG INJECTION 15ML or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. UNICARB 150MG INJECTION 15ML should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking UNICARB 150MG INJECTION 15ML if you are pregnant or breastfeeding because this UNICARB 150MG INJECTION 15ML can cause harmful effects on the unborn baby. Both women and men using this UNICARB 150MG INJECTION 15ML should use birth control to avoid pregnancy.
Uses of UNICARB 150MG INJECTION 15ML
Medicinal Benefits
UNICARB 150MG INJECTION 15ML contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.
Directions for Use
Storage
Side Effects of UNICARB 150MG INJECTION 15ML
Drug Warnings
UNICARB 150MG INJECTION 15ML should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking UNICARB 150MG INJECTION 15ML. To treat your condition effectually, continue taking UNICARB 150MG INJECTION 15ML for as long as your doctor has prescribed. Do not stop the UNICARB 150MG INJECTION 15ML midway. Talk to your doctor before taking UNICARB 150MG INJECTION 15ML if you have severe allergic reactions to UNICARB 150MG INJECTION 15ML or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. UNICARB 150MG INJECTION 15ML should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking UNICARB 150MG INJECTION 15ML if you are pregnant or breastfeeding because this UNICARB 150MG INJECTION 15ML can cause harmful effects on the unborn baby. Both women and men using this UNICARB 150MG INJECTION 15ML should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during UNICARB 150MG INJECTION 15ML treatment and appropriate until recovery is achieved.
Drug Interactions
Drug-Drug Interactions: UNICARB 150MG INJECTION 15ML interacts with medicines used in the treatment of chemotherapy (e.g. pemetrexed, gemcitabine, pegfilgrastim, paclitaxel, docetaxel), antacid medications (e.g. pantoprazole) and antibiotic medications (e.g. amikacin, gentamicin, kanamycin, streptomycin, tobramycin).
Drug-Food Interactions: No food interaction was found.
Drug-Disease Interactions: Inform your doctor before taking UNICARB 150MG INJECTION 15ML it requires close monitoring if you are suffering from Infection (bacterial/fungal/protozoal/viral), bleeding disorders, bone marrow depression/low blood counts, fever, renal dysfunction or disorders, peripheral neuropathy (nerves malfunction).
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
Special Advise
Disease/Condition Glossary
Ovarian cancer: Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed).
Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.